Trial in progress

Does durvalumab make curative chemoradiation work better?

KUNLUN · AstraZeneca · 640 people at 133 sites worldwide · Registered completion June 2027

Fully enrolled, waiting on resultsRegistered completion June 2027

What is being tested

Durvalumab or placebo, given during and after chemoradiation, for squamous esophageal cancer that cannot be removed by surgery.

Why it matters

The last large worldwide test of this idea. Two similar trials, KEYNOTE-975 and SKYSCRAPER-07, missed.

ClinicalTrials.gov record ↗ ← Back to the outlook

Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.